See also this year's filing and all EDGAR filings for this company.
PDF Report 0001005201_2018_Assertio_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001005201')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001005201, Assertio Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 230,851,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 793,873,000 |
| 2 | PropertyPlantAndEquipmentNet | 13,024,000 |
| 3 | remainder_Assets | 869,000 |
| 4 | LiabilitiesCurrent | 310,580,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 195,696,000 |
| 9 | ResearchAndDevelopmentExpense | 13,718,000 |
| 10 | remainder_Expenses | 212,061,000 |
| 11 | remainder_Revenues | 380,724,000 |
| 12 | remainder_NetIncome | -61,745,000 |
| 13 | remainder_ComprehensiveNetIncome | 14,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,038,617,000 |
| 1 | Liabilities | 310,580,000 |
| 2 | Expenses | 421,475,000 |
| 3 | Revenues | 380,724,000 |
| 4 | StockholdersEquity | 728,037,000 |
| 5 | NetIncome | -102,496,000 |
| 6 | ComprehensiveNetIncome | -102,489,000 |
| 7 | BaseVar | 1,106,577,500 |
| 8 | EconomicCapitalRatio | 1.70 |
Edgar->Model Mapping
Feature Distribution
Change over Time
